Immune-Onc Therapeutics, Inc. (“Immune-Onc”) is a clinical-stage cancer immunotherapy company dedicated to the discovery and development of novel myeloid checkpoint inhibitors for cancer patients. Headquartered in Palo Alto, California, Immune-Onc has assembled a diverse team with deep expertise in drug development and proven track records of success at leading biotechnology companies.

Biotechnology

Pharmaceutical

Therapeutics

Immune-Onc Therapeutics

Immune-Onc Therapeutics' headquarters in Palo Alto, CA, United States

Charlene Liao

Helen Y.

Ying Zhu

Xiao Min Schebye

Penny Dong

Hong Xiang

Maggie Gu

Chengcheng Zhang

Feng Deng

Liqun Luo

Michael Karin

Zhiqiang An

Austin Gurney

Jack Donahue

Guo-Liang Yu

Stuart Lutzker

Dave Chenn

Greg Cosma

Barbara Klencke

Description

People (3)

Hong Xiang

Xiao Min Schebye

Ying Zhu

Jobs